RIN2 is a Rab5 guanine nucleotide exchange factor that couples Ras-family GTPase signaling to early endocytic trafficking, governing receptor internalization and matrix homeostasis (PMID:16423831, PMID:22825554). Containing both a Vps9p-like GEF domain and Ras-association domains, RIN2 acts downstream of activated Ras: HGF-stimulated Ras binds and activates RIN2 to catalyze GDP-to-GTP exchange on Rab5, driving endocytosis of E-cadherin from adherens junctions, a step dependent on its GEF activity (PMID:16423831). In endothelial cells, binding of R-Ras-GTP switches RIN2 from a Rab5 GEF into a Rab5-GTP adaptor that selectively internalizes ligand-bound active β1 integrins and translocates R-Ras to early endosomes, where the R-Ras/RIN2/Rab5 module activates Rac1 through TIAM1 to promote cell adhesion and angiogenesis (PMID:22825554). Loss-of-function frameshift mutations in humans cause depletion of RIN2 and a connective tissue disorder marked by paucity of dermal microfibrils, fibulin-5 deficiency, and abnormal collagen fibril and secretory organelle morphology, establishing RIN2-dependent trafficking as required for normal elastic and connective tissue matrix assembly (PMID:19631308, PMID:20424861).